PsiThera
psithera.com
Actively hiring
Drug Discovery
Drug Discovery AI
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$47.5M
1 round on record
Latest round
$47.5M
Series A · Dec 2025 · 9 mo ago
Team
51-200
employees, estimated range
Hiring now
1
open roles
Backers
1
Lightstone Ventures
The money's age
Fresh money
9 months since the last round · hiring slowed
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Dec 2025 | $47.5M | — | news.qq.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Lightstone Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Astraveus is a biotech startup based in Paris, France. We strive to enable a healthier tomorrow. We believe in the therapeutic potential of…
Chemical.AI’s software leverages AI to help scientists uncover innovative synthetic pathways for both novel and established target…
immunitoAI is an AI-driven biotechnology company accelerating antibody discovery and the development of antibody-based therapies through…
Vilya creates macrocycles using AI and synthetic biology, designing novel therapeutics inspired by nature, beyond evolution’s reach.
AllRock Bio is leveraging extensive expertise from drug development to commercialization. AllRock Bio’s team is dedicated to advancing…
MediSix Therapeutics develops innovative T-cell therapies using its proprietary PEBL technology platform. An IASO Biotechnology subsidiary.
News
PsiThera to Participate in PiperSandler Virtual Novel Targets inImmunologySymposium
WATERTOWN, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PsiThera, Inc. today announced that Chief Executive Officer Eric Shaff, Founder and Chief Innovation Officer Woody Sherman, Ph.D., and Chief Scientific Officer Camil Sayegh, Ph.D., will participate in a
Read more
Report
PsiThera to Participate in Piper Sandler Virtual Novel Targets in Immunology Symposium
Watertown, Mass., February 12, 2026 (GLOBE NEWSWIRE) - PsiThera, Inc. today announced that Chief Executive Officer Eric Shaff, Founder and Chief Innovation Officer Woody Sherman, Ph.D., and Chief Scientific Officer Camil Sayegh, Ph.D., will participate in
Read more
Report
PsiThera获得4750万美元A轮融资_腾讯新闻
PsiThera是一家免疫炎症口服药物研发商主要通过整合量子化学、分子动力学、机器学习和超级计算从事小分子药物研发业务近日PsiThera宣布完成4750万美元A轮融资任命Eric Shaff为首席执行官本轮融资由Samsara Biocapital和Lightstone Ventures领投Roivant、YK Bioventures、Eurofarma Ventures等顶级投资者参与...
Read more
Report
PsiThera Unveiled with Newly Appointed CEO and $47.5 Million Series A to Advance Oral Medicines for Validated I&I Targets
$47.5 million Series A financing led by Samsara Biocapital and Lightstone Ventures to advance PsiThera's growing pipeline, starting with multiple clinically validated TNF superfamily preclinical programsBiotech veteran Eric Shaff appointed CEO and joins e
Read more
Report
Star Tribune
Your source for Minnesota news today. Read articles, view photos or watch videos about news in Minneapolis, St. Paul, Duluth, St. Cloud, Rochester, and beyond.
Read more
Report
PsiThera Unveiled with Newly Appointed CEO and $47.5 Million Series A to Advance Oral Medicines for Validated I&I Targets
Watertown, MA, December 10, 2025 - PsiThera, a biotech company harnessing biologically relevant protein states and computational intelligence to create oral drugs for diseases long-constrained by injectable-only approaches, announced today that it has clo
Read more
Report
PsiThera launches with $47 million and computational chemistry tools
After starting life as a Roivant spinout, the start-up is stepping out on its own
Read more
Report
Tech stack
Technologies named in job postings at PsiThera over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
85/100
Practices & domains
Machine Learning
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$200k
Typical range
$200k
Open positions
1
1
Jobs
Principal
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Principal | 1 | $200k | $200k |
Highest paying role
Principal Scientist, Medicinal Chemistry
$200k
Normalized to USD per year
Growth
Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~3 hours
Today
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
100% ▼
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Watertown
Watertown
United States
HQ
PsiThera
1 open roles 1 posted in 90 days 100% engineering 50-200 est. staff $200k Avg Salary
hires for Science & Research
66 Galen Street, Suite 202, Watertown, MA 02472
Financials
Total raised
$47.5M
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2025 | $47.5M | Details |